RADIOPHARM THERANOSTICS LIMITED - Announcements

8.82%

3.1¢

Market Cap $73.31M

Healthcare Biotechnology

Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics... Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer. The clinical program includes one Phase II and three Phase I trials in a variety of solid tumor cancers including lung, breast, and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RAD	Update - Proposed issue of securities - RAD		09/08/24	22.06KB	Share
RAD	Update - Proposed issue of securities - RAD		09/08/24	24.66KB	Share
RAD	Prospectus		09/08/24	1.28MB	Share
RAD	Radiopharm receives US$2.0 M payment from Lantheus		05/08/24	181.09KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	807.73KB	Share
RAD	Radiopharm targets Nasdaq Listing by end of 2024		26/07/24	162.75KB	Share
RAD	FDA IND approval for Phase 2b trial in brain metastases	PRICE SENSITIVE	23/07/24	156.63KB	Share
RAD	Correction to Notice of Extraordinary General Meeting		17/07/24	249.24KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		16/07/24	536.36KB	Share
RAD	First patient dosed in Phase 1 therapeutic lung cancer trial	PRICE SENSITIVE	10/07/24	204.12KB	Share
RAD	Ceasing to be a substantial holder		08/07/24	278.15KB	Share
RAD	Change in substantial holding PH		05/07/24	263.92KB	Share
RAD	Becoming a substantial holder		03/07/24	619.08KB	Share
RAD	Becoming a substantial holder		03/07/24	779.54KB	Share
RAD	GN20 Disclosure		03/07/24	597.33KB	Share
RAD	Notice Under Section 708A		02/07/24	124.15KB	Share
RAD	RAD notifies end of share agreements with Lind Partners		02/07/24	126.62KB	Share
RAD	Application for quotation of securities - RAD		01/07/24	15.71KB	Share
RAD	Investor webinar 3pm AEST Tuesday 2 July		27/06/24	152.2KB	Share
RAD	Reinstatement to Quotation	PRICE SENSITIVE	25/06/24	86KB	Share
RAD	Proposed issue of securities - RAD		25/06/24	21.97KB	Share
RAD	Proposed issue of securities - RAD		25/06/24	15.96KB	Share
RAD	Lantheus Strategic Investment and Capital Raise Presentation		25/06/24	3.28MB	Share
RAD	Radiopharm Theranostics completes A$70 million placement	PRICE SENSITIVE	25/06/24	229.95KB	Share
RAD	Suspension from Quotation	PRICE SENSITIVE	24/06/24	512.18KB	Share
RAD	Proposed issue of securities - RAD		20/06/24	24.53KB	Share
RAD	Radiopharm Receives Strategic Investment for up to A$18 mill	PRICE SENSITIVE	20/06/24	206.06KB	Share
RAD	Trading Halt	PRICE SENSITIVE	20/06/24	185.1KB	Share
RAD	Change in substantial holding NanoMab		23/05/24	748.95KB	Share
RAD	Change in substantial holding PH		23/05/24	264.07KB	Share
RAD	Notice Under Section 708A		16/05/24	124.05KB	Share
RAD	Application for quotation of securities - RAD		16/05/24	16.24KB	Share
RAD	RAD to be featured at B. Riley Securities Healthcare events		08/05/24	232.73KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	1.4MB	Share
RAD	Notification regarding unquoted securities - RAD		24/04/24	16.99KB	Share
RAD	Radiopharm Ventures institutional & VC presentation		22/04/24	2.42MB	Share
RAD	Notice Under Section 708A		15/04/24	123.71KB	Share
RAD	Application for quotation of securities - RAD		15/04/24	15.68KB	Share
RAD	Results of Extraordinary General Meeting		15/04/24	129.42KB	Share
RAD	Presentation to Extraordinary General Meeting		15/04/24	574.69KB	Share
RAD	Initial Director's Interest Notice PH		26/03/24	238.44KB	Share
RAD	Final Director's Interest Notice MB		26/03/24	264.37KB	Share
RAD	Board Changes		26/03/24	183.12KB	Share
RAD	RAD to present at NWR Virtual Healthcare Conference		19/03/24	204.51KB	Share
RAD	RAD 301 and 302 data shows value of targeting avb6-integrin		15/03/24	381.24KB	Share
RAD	Notice of Extraordinary General Meeting/Proxy Form		15/03/24	704.35KB	Share
RAD	Notice Under Section 708A		12/03/24	124.06KB	Share
RAD	Application for quotation of securities - RAD		12/03/24	15.85KB	Share
RAD	Multiple RAD301 data releases to be presented at EMIM		06/03/24	254.09KB	Share
RAD	Notice Under Section 708A		04/03/24	123.77KB	Share
RAD	Application for quotation of securities - RAD		04/03/24	16.03KB	Share
RAD	B Riley Securities Radiopharma Conference Presentation		04/03/24	1.16MB	Share
RAD	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	1.55MB	Share
RAD	Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301	PRICE SENSITIVE	29/02/24	288.52KB	Share
RAD	Pilot Study Validates RAD Terbium-161 Radiotherapeutics	PRICE SENSITIVE	28/02/24	265.19KB	Share
RAD	Participation in B. Riley Securities Radiopharma Conference		23/02/24	204KB	Share
RAD	Radiopharm receives $1.9 M advance on FY24 R&D tax incentive	PRICE SENSITIVE	21/02/24	147.07KB	Share
RAD	Notice Under Section 708A		14/02/24	123.9KB	Share
RAD	Application for quotation of securities - RAD		14/02/24	15.89KB	Share
RAD	Application for quotation of securities - RAD		09/02/24	15.96KB	Share
RAD	Update - Proposed issue of securities - RAD		06/02/24	15.75KB	Share
RAD	RAD Share Facility Agreement of up to A$12.5m addendum		06/02/24	312.65KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	17.07KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	15.34KB	Share
RAD	Proposed issue of securities - RAD		06/02/24	15.47KB	Share
RAD	RAD secures Share Facility Agreement of up to A$12.5m	PRICE SENSITIVE	06/02/24	308.86KB	Share
RAD	RAD 502 can halt tumour progression and prolong survival	PRICE SENSITIVE	05/02/24	308.3KB	Share
RAD	Application for quotation of securities - RAD		31/01/24	25.09KB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	325.51KB	Share
RAD	Investor Presentation		24/01/24	1.54MB	Share
RAD	Placement of Entitlement Offer Shortfall	PRICE SENSITIVE	24/01/24	214.49KB	Share
RAD	Notice Under Section 708A		05/01/24	123.87KB	Share
RAD	Application for quotation of securities - RAD		05/01/24	25.53KB	Share
RAD	2nd Australian site for Nanomab-PDL-1 Phase 1 trial	PRICE SENSITIVE	27/12/23	303.62KB	Share
RAD	Notification regarding unquoted securities - RAD		22/12/23	23.81KB	Share
RAD	Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan	PRICE SENSITIVE	22/12/23	268.51KB	Share
RAD	Change of Director's Interest Notice x5		15/12/23	339.11KB	Share
RAD	Notice Under Section 708A		15/12/23	123.77KB	Share
RAD	Application for quotation of securities - RAD		15/12/23	25.49KB	Share
RAD	Application for quotation of securities - RAD		08/12/23	25.05KB	Share
RAD	Completion of Entitlement Offer	PRICE SENSITIVE	08/12/23	162.94KB	Share
RAD	Change of Director's Interest Notice - PH IT RC		07/12/23	401.54KB	Share
RAD	Notification regarding unquoted securities - RAD		01/12/23	27.06KB	Share
RAD	Application for quotation of securities - RAD		24/11/23	25.21KB	Share
RAD	Amended Constitution		22/11/23	594.02KB	Share
RAD	Radiopharm receives $4.85M R&D tax incentive	PRICE SENSITIVE	21/11/23	148.63KB	Share
RAD	Update - Proposed issue of securities - RAD		21/11/23	28.34KB	Share
RAD	Entitlement Offer closing date extended to 1 December 2023		21/11/23	136.94KB	Share
RAD	Notification of Release of Shares from Escrow		16/11/23	145.03KB	Share
RAD	Results of Annual General Meeting		16/11/23	127.94KB	Share
RAD	Presentation to Annual General Meeting		16/11/23	737.12KB	Share
RAD	Bell Potter Healthcare Conference Presentation		15/11/23	1.62MB	Share
RAD	Entitlement Offer Documents	PRICE SENSITIVE	08/11/23	5.39MB	Share
RAD	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	1.47MB	Share
RAD	Entitlement Offer cleansing notice under section 708AA		31/10/23	211.73KB	Share
RAD	Proposed issue of securities - RAD		31/10/23	24.47KB	Share
RAD	Investor webinar		31/10/23	131.08KB	Share
RAD	Proposed issue of securities - RAD		31/10/23	28.68KB	Share
RAD	Investor Presentation - Entitlement Offer		31/10/23	1.56MB	Share
RAD	Entitlement Offer to raise approximately $10 million	PRICE SENSITIVE	31/10/23	228.3KB	Share

RAD Update - Proposed issue of securities - RAD
09/08/24		22.06KB	Share
RAD Update - Proposed issue of securities - RAD
09/08/24		24.66KB	Share
RAD Prospectus
09/08/24		1.28MB	Share
RAD Radiopharm receives US$2.0 M payment from Lantheus
05/08/24		181.09KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	807.73KB	Share
RAD Radiopharm targets Nasdaq Listing by end of 2024
26/07/24		162.75KB	Share
RAD FDA IND approval for Phase 2b trial in brain metastases
23/07/24	PRICE SENSITIVE	156.63KB	Share
RAD Correction to Notice of Extraordinary General Meeting
17/07/24		249.24KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
16/07/24		536.36KB	Share
RAD First patient dosed in Phase 1 therapeutic lung cancer trial
10/07/24	PRICE SENSITIVE	204.12KB	Share
RAD Ceasing to be a substantial holder
08/07/24		278.15KB	Share
RAD Change in substantial holding PH
05/07/24		263.92KB	Share
RAD Becoming a substantial holder
03/07/24		619.08KB	Share
RAD Becoming a substantial holder
03/07/24		779.54KB	Share
RAD GN20 Disclosure
03/07/24		597.33KB	Share
RAD Notice Under Section 708A
02/07/24		124.15KB	Share
RAD RAD notifies end of share agreements with Lind Partners
02/07/24		126.62KB	Share
RAD Application for quotation of securities - RAD
01/07/24		15.71KB	Share
RAD Investor webinar 3pm AEST Tuesday 2 July
27/06/24		152.2KB	Share
RAD Reinstatement to Quotation
25/06/24	PRICE SENSITIVE	86KB	Share
RAD Proposed issue of securities - RAD
25/06/24		21.97KB	Share
RAD Proposed issue of securities - RAD
25/06/24		15.96KB	Share
RAD Lantheus Strategic Investment and Capital Raise Presentation
25/06/24		3.28MB	Share
RAD Radiopharm Theranostics completes A$70 million placement
25/06/24	PRICE SENSITIVE	229.95KB	Share
RAD Suspension from Quotation
24/06/24	PRICE SENSITIVE	512.18KB	Share
RAD Proposed issue of securities - RAD
20/06/24		24.53KB	Share
RAD Radiopharm Receives Strategic Investment for up to A$18 mill
20/06/24	PRICE SENSITIVE	206.06KB	Share
RAD Trading Halt
20/06/24	PRICE SENSITIVE	185.1KB	Share
RAD Change in substantial holding NanoMab
23/05/24		748.95KB	Share
RAD Change in substantial holding PH
23/05/24		264.07KB	Share
RAD Notice Under Section 708A
16/05/24		124.05KB	Share
RAD Application for quotation of securities - RAD
16/05/24		16.24KB	Share
RAD RAD to be featured at B. Riley Securities Healthcare events
08/05/24		232.73KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	1.4MB	Share
RAD Notification regarding unquoted securities - RAD
24/04/24		16.99KB	Share
RAD Radiopharm Ventures institutional & VC presentation
22/04/24		2.42MB	Share
RAD Notice Under Section 708A
15/04/24		123.71KB	Share
RAD Application for quotation of securities - RAD
15/04/24		15.68KB	Share
RAD Results of Extraordinary General Meeting
15/04/24		129.42KB	Share
RAD Presentation to Extraordinary General Meeting
15/04/24		574.69KB	Share
RAD Initial Director's Interest Notice PH
26/03/24		238.44KB	Share
RAD Final Director's Interest Notice MB
26/03/24		264.37KB	Share
RAD Board Changes
26/03/24		183.12KB	Share
RAD RAD to present at NWR Virtual Healthcare Conference
19/03/24		204.51KB	Share
RAD RAD 301 and 302 data shows value of targeting avb6-integrin
15/03/24		381.24KB	Share
RAD Notice of Extraordinary General Meeting/Proxy Form
15/03/24		704.35KB	Share
RAD Notice Under Section 708A
12/03/24		124.06KB	Share
RAD Application for quotation of securities - RAD
12/03/24		15.85KB	Share
RAD Multiple RAD301 data releases to be presented at EMIM
06/03/24		254.09KB	Share
RAD Notice Under Section 708A
04/03/24		123.77KB	Share
RAD Application for quotation of securities - RAD
04/03/24		16.03KB	Share
RAD B Riley Securities Radiopharma Conference Presentation
04/03/24		1.16MB	Share
RAD Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	1.55MB	Share
RAD Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301
29/02/24	PRICE SENSITIVE	288.52KB	Share
RAD Pilot Study Validates RAD Terbium-161 Radiotherapeutics
28/02/24	PRICE SENSITIVE	265.19KB	Share
RAD Participation in B. Riley Securities Radiopharma Conference
23/02/24		204KB	Share
RAD Radiopharm receives $1.9 M advance on FY24 R&D tax incentive
21/02/24	PRICE SENSITIVE	147.07KB	Share
RAD Notice Under Section 708A
14/02/24		123.9KB	Share
RAD Application for quotation of securities - RAD
14/02/24		15.89KB	Share
RAD Application for quotation of securities - RAD
09/02/24		15.96KB	Share
RAD Update - Proposed issue of securities - RAD
06/02/24		15.75KB	Share
RAD RAD Share Facility Agreement of up to A$12.5m addendum
06/02/24		312.65KB	Share
RAD Proposed issue of securities - RAD
06/02/24		17.07KB	Share
RAD Proposed issue of securities - RAD
06/02/24		15.34KB	Share
RAD Proposed issue of securities - RAD
06/02/24		15.47KB	Share
RAD RAD secures Share Facility Agreement of up to A$12.5m
06/02/24	PRICE SENSITIVE	308.86KB	Share
RAD RAD 502 can halt tumour progression and prolong survival
05/02/24	PRICE SENSITIVE	308.3KB	Share
RAD Application for quotation of securities - RAD
31/01/24		25.09KB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	325.51KB	Share
RAD Investor Presentation
24/01/24		1.54MB	Share
RAD Placement of Entitlement Offer Shortfall
24/01/24	PRICE SENSITIVE	214.49KB	Share
RAD Notice Under Section 708A
05/01/24		123.87KB	Share
RAD Application for quotation of securities - RAD
05/01/24		25.53KB	Share
RAD 2nd Australian site for Nanomab-PDL-1 Phase 1 trial
27/12/23	PRICE SENSITIVE	303.62KB	Share
RAD Notification regarding unquoted securities - RAD
22/12/23		23.81KB	Share
RAD Phase 1 Therapeutic NSCLC (Lung Cancer) Trial Opens 4 Jan
22/12/23	PRICE SENSITIVE	268.51KB	Share
RAD Change of Director's Interest Notice x5
15/12/23		339.11KB	Share
RAD Notice Under Section 708A
15/12/23		123.77KB	Share
RAD Application for quotation of securities - RAD
15/12/23		25.49KB	Share
RAD Application for quotation of securities - RAD
08/12/23		25.05KB	Share
RAD Completion of Entitlement Offer
08/12/23	PRICE SENSITIVE	162.94KB	Share
RAD Change of Director's Interest Notice - PH IT RC
07/12/23		401.54KB	Share
RAD Notification regarding unquoted securities - RAD
01/12/23		27.06KB	Share
RAD Application for quotation of securities - RAD
24/11/23		25.21KB	Share
RAD Amended Constitution
22/11/23		594.02KB	Share
RAD Radiopharm receives $4.85M R&D tax incentive
21/11/23	PRICE SENSITIVE	148.63KB	Share
RAD Update - Proposed issue of securities - RAD
21/11/23		28.34KB	Share
RAD Entitlement Offer closing date extended to 1 December 2023
21/11/23		136.94KB	Share
RAD Notification of Release of Shares from Escrow
16/11/23		145.03KB	Share
RAD Results of Annual General Meeting
16/11/23		127.94KB	Share
RAD Presentation to Annual General Meeting
16/11/23		737.12KB	Share
RAD Bell Potter Healthcare Conference Presentation
15/11/23		1.62MB	Share
RAD Entitlement Offer Documents
08/11/23	PRICE SENSITIVE	5.39MB	Share
RAD Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	1.47MB	Share
RAD Entitlement Offer cleansing notice under section 708AA
31/10/23		211.73KB	Share
RAD Proposed issue of securities - RAD
31/10/23		24.47KB	Share
RAD Investor webinar
31/10/23		131.08KB	Share
RAD Proposed issue of securities - RAD
31/10/23		28.68KB	Share
RAD Investor Presentation - Entitlement Offer
31/10/23		1.56MB	Share
RAD Entitlement Offer to raise approximately $10 million
31/10/23	PRICE SENSITIVE	228.3KB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.1¢		Change -0.003(8.82%)		Mkt cap ! $73.31M

Open	High	Low	Value	Volume
3.4¢	3.4¢	3.1¢	$58.95K	1.821M

Buyers (Bids)

No.	Vol.	Price($)
4	783888	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.2¢	870662	1

View Market Depth

No.	Vol.	Price($)
4	783888	0.031
3	1230000	0.030
6	505133	0.029
3	649718	0.028
5	1761111	0.027

Price($)	Vol.	No.
0.032	870662	1
0.033	877110	2
0.034	1290328	3
0.035	2373494	10
0.036	1165378	3

Last trade - 16.10pm 19/09/2025 (20 minute delay)

RAD (ASX) Chart

RADIOPHARM THERANOSTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available